 DUBLIN, Dec. 29, 2020 PRNewswire -- Alkermes plc Nasdaq: ALKS today announced that the U.S. Food and Drug Administration FDA has acknowledged receipt of the companys New Drug Application NDA resubmission for ALKS 3831 olanzapinesamidorphan for the treatment of adults with... 